Dizal Pharmaceutical Executives Including CFO Lu Hongbin Plan to Reduce Shareholdings

Hong Kong Stocks Close Lower as Oil Shares Rise Against the Trend, While Materials, Pharma and Tech Stocks Face Pressure

GenFleet Therapeutics-B Director Tao Sha Steps Down from Non-Executive Role

Healthcare Sector's Low Position and Turning Point

Pharma Sector Revenue Pressures Persist, Flu Season Offers Potential Catalyst, Says Guosheng Securities

GENFLEET-B (02595) Share Transfer Worth HK$912 Million, Accounting for 9.11%, with 24.59 Million Shares Moved Out of China Securities Depository and Clearing

INNOVENT BIO Posts Robust Growth on Dual Momentum From Oncology and Integrated Product Lines

Genfleet-B Surges Over 9% Intraday As GFH375 Combination Therapy Moves Toward Breakthrough Therapy Designation

GENFLEET-B (02595) Outlines Schedule for Upcoming Clinical Data Presentations Concerning GFH375 and GFH276

Pharmaceutical Sector Gains Momentum as Two Legacy Drugmakers Log Back-to-Back Limit-Ups, With a Reminder for Investors to Stay Rational

Yahong Meditech's APL-2501 Doses First Patient in Phase I Study for Advanced Solid Tumors

Healthcare and Property Sectors Rally, Over 4,500 Stocks Advance Across Both Markets | Huabao Fund 3A Daily Report (September 21, 2026)

Meilleure Health International (02327) to Acquire Full Stake in Dexin Pharma Development for HK$35.2 Million

Shanghai Composite Adds 0.97%, ChiNext Up 0.8%: Property and Pharma Lead Gains as Over 4,500 Stocks Advance

Shares of TRANSCENTA-B Surge Over 29% Intraday After Chairman Qian Xueming Increases Stake

GENFLEET-B (02595) Posts HK$1.125 Billion Transfer in Share Movement, Accounting for 12.80% of Holdings

GENFLEET-B Announces H-Share Buyback Totaling 872,000 Shares as of September 18

China Securities: Small-Cap Growth Outperforms While Healthcare Funds Show Strong Weekly Gains

H Share Subscription Deal Between TYK Medicines and Qilu Expires

Yan'an Pharma Withdraws Beijing IPO for Second Time, Sees Nearly Doubled Fundraising Target Questioned